Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Drug Daily Bulletin > Glenmark Pharma Arm Gets Tentative Nod for Rizatriptan Benzoate

FDAnews Drug Daily Bulletin

Sept. 21, 2012 | Vol. 9 No. 186

Glenmark Pharma Arm Gets Tentative Nod for Rizatriptan Benzoate

Glenmark Pharmaceuticals said Glenmark Generics had obtained tentative nod from the FDA for rizatriptan benzoate tablets, its generic version of Merck’s Maxalt tablets.
RTTnews

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Full Issue Experts Spar Over FDA Meeting To Re-Evaluate GSK’s Avandia Shionogi Gets Untitled Letter After Refusing To Conduct Postmarketing Study J&J Eyes Growth Spurt With 10 New Product Launches Planned by 2017

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.